Key points
- Pharmacovigilance systems must define functional roles across operations, medical, quality, and regulatory functions.
- Each role must have clearly defined responsibilities aligned with PV processes.
- Operational roles must manage case intake, processing, and reporting.
- Medical roles must assess causality, expectedness, and clinical interpretation.
- Quality roles must ensure compliance, audit readiness, and CAPA implementation.
- Regulatory roles must manage submissions, authority communication, and compliance obligations.
What inspectors expect
Each point below should be supported by controlled documents and traceable records.
- Functional PV roles must be clearly defined and documented.
- Responsibilities must align with PV processes and regulatory requirements.
- Functions must interact effectively to support compliance.
- Each role must support accurate and timely safety reporting.
- The PV system must be supported by coordinated functional execution.
Summary
Inspectors assess whether pharmacovigilance systems define and implement functional roles across operations, medical, quality, and regulatory functions. They review how responsibilities are allocated, how functions interact, and whether each role supports compliant execution of PV activities. Functional roles must operate in a defined workflow from case intake through medical review, quality control, and regulatory submission.
Common questions
These are the questions this page is designed to answer directly.
- What are the key pharmacovigilance roles?
- What do PV operations teams do?
- What is the role of a safety physician in pharmacovigilance?
- What does PV quality assurance do?
- What is the role of regulatory in pharmacovigilance?
- How are PV roles divided across functions?
- What do inspectors check for functional PV roles?
- Who processes ICSRs in pharmacovigilance?
- Who performs medical review in PV?
- How are responsibilities divided in PV teams?
Evidence objects inspectors expect
PV Operations Roles
- Case intake and data entry responsibilities
- ICSR processing workflows
- Follow-up activities and case completion
- Compliance with reporting timelines
Medical Review Roles
- Causality and expectedness assessment
- Clinical interpretation of case data
- Signal identification and escalation
- Medical review documentation
Quality Assurance Roles
- Quality control of ICSR data
- Audit and inspection readiness activities
- CAPA management and tracking
- Compliance monitoring and deviation management
Regulatory Affairs Roles
- Submission of ICSRs to health authorities
- Management of regulatory queries
- Coordination of aggregate reporting
- Communication with regulators
Cross-Functional Interaction
- Interaction between operations and medical review
- QA oversight of operational processes
- Regulatory coordination with PV functions
- Escalation of safety issues across functions
Regulatory Basis (Primary Sources)
- GVP Module I – requirement for defined PV organisational structure
- GVP Module VI – responsibilities across case processing and reporting
- ICH E2D – structured safety data management responsibilities
- MHRA GPvP guidance – expectations for PV functional roles
- FDA pharmacovigilance guidance – allocation of responsibilities across functions
Typical Inspection Questions (What Inspectors Ask)
- Who processes ICSRs in your organisation?
- Who performs medical review of cases?
- How is quality assurance performed in PV?
- Who is responsible for regulatory submissions?
- How do these functions interact in practice?
Failure patterns
Roles are defined but not aligned with actual activities.
Gaps exist between operational, medical, QA, and regulatory functions.
Functions operate in silos without coordination.
Responsibilities overlap or are unclear.
Quality or regulatory activities are not integrated into PV processes.
What good looks like
- Clearly defined roles across all PV functions.
- Alignment between role definitions and operational practice.
- Effective interaction between operations, medical, QA, and regulatory teams.
- Integrated processes supporting compliance and safety oversight.
- Clear ownership of each PV activity.
Operationalisation
- Define functional roles within PV SOPs.
- Assign responsibilities for each stage of the PV process.
- Ensure coordination between operational, medical, QA, and regulatory teams.
- Train staff on their roles and responsibilities.
- Monitor functional performance through KPIs and audits.
- Align roles with regulatory requirements and system needs.
Need regulatory documentation today?
Save time and reduce inspection risk with structured, pre-built process-ready documentation.
Created by industry professionals, adaptable to your organisation.
Related pre-built documentation inside the app
FAQ
What are the roles in a pharmacovigilance team?
A pharmacovigilance team typically includes PV operations staff responsible for case processing, safety physicians responsible for medical assessment, quality assurance ensuring compliance and audit readiness, and regulatory functions managing submissions and authority communication.
What are the key roles in pharmacovigilance?
Key roles include PV operations staff, safety physicians, quality assurance personnel, regulatory affairs professionals, and oversight roles such as the QPPV.
What does PV operations do?
PV operations manage case intake, data entry, processing, follow-up, and ensure compliance with reporting timelines.
What is the role of medical review in pharmacovigilance?
Medical review assesses causality, expectedness, and clinical interpretation of safety data.
What does PV quality assurance do?
QA ensures compliance, performs audits, manages CAPA, and maintains inspection readiness.
What is the role of regulatory affairs in pharmacovigilance?
Regulatory functions manage submissions, authority communication, and compliance with reporting requirements.
How do these roles work together?
These roles interact through structured processes, governance, and escalation pathways to ensure compliant pharmacovigilance operations.
Sources
Primary guidance used to inform this map. This page is a structured interpretation layer; always validate against the original source documents.
European Medicines Agency (EMA)
- Guideline on good pharmacovigilance practices (GVP) – Module IView source
- Guideline on good pharmacovigilance practices (GVP) – Module VIView source
FDA
- Postmarketing Safety ReportingView source
ICH
- Post-Approval Safety Data Management (E2D)View source
MHRA
- Good Pharmacovigilance Practice (GPvP)View source